跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
必利劲 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Dapoxetine Hydrochloride Tablets
Approved
化学药品
Dapoxetine Hydrochloride Tablets
BERLIN-CHEMIE AG
🇨🇳 National Medical Products Administration
Approval Date
Apr 1, 2020
Approval ID
7MazXbxPDhU
Company
BERLIN-CHEMIE AG
Type
化学药品
Approval Details
Approval Id
7MazXbxPDhU
Approval Number
H20150563
Generic Name
盐酸达泊西汀片
Generic Name En
Dapoxetine Hydrochloride Tablets
Trade Name
必利劲
Brand Name
必利劲
Drug Type
化学药品
Dosage Form
片剂
Strength
30mg
Reg Date
2020-04-01
Expired Date
2025-03-31
Company Name
BERLIN-CHEMIE AG
Company Address
Glienicker Weg 125 12489 Berlin Federal Republic of Germany
Production Company Name
Menarini - Von Heyden GmbH
Production Company Address
Leipziger Straβe 7-13 01097 Dresden Federal Republic of Germany
Company Detail Path
/organization/berlin-chemie-ag
Production Company Detail Path
/organization/menarini-von-heyden-gmbh
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Apr 1, 2020
Approval ID
7MazXbxPDhU
Type
化学药品
Back to NMPA Approvals